Beam details reasons for FDA hold on base editing cancer therapy

cafead

Administrator
Staff member
  • cafead   Sep 01, 2022 at 10:32: AM
via The Food and Drug Administration is asking Beam Therapeutics for a range of technical data on an experimental gene editing cancer therapy before allowing the company to begin human testing.

article source